Table 1.
Characteristics of clinical baseline. FSH: follicle-stimulating hormone; LH: luteinizing hormone; E2: Estradiol; PRL: prolactin; P: progesterone; T: testosterone; AMH: Anti-Mullerian hormone; data was show as Mean ± SD or Median (25 %quantile,75 % quantile)
| Characteristics | Control(n = 21) | PCOS(n = 22) | P value |
|---|---|---|---|
| Age | 28.52 ± 3.63 | 28.05 ± 3.11 | > 0.05 |
| BMI | 20.54 ± 1.77 | 23.51 ± 4.15 | > 0.05 |
| FSH (mIU/ml) | 7.62 ± 1.99 | 6.65 ± 1.53 | > 0.05 |
| LH (mIU/ml) | 4.14(3.22,5.38) | 10.18 ± 6.08 | < 0.05 |
| LH/FSH | 0.62 ± 0.25 | 1.14(0.86,2.12) | < 0.05 |
| E2 (pg/ml) | 43.12 ± 15.87 | 44.49(38.68,59.29) | > 0.05 |
| PRL (ng/ml) | 16.41 ± 7.04 | 10.58(8.17,12.70) | < 0.05 |
| P(ng/ml) | 0.65(0.44,0.80) | 0.64 ± 0.41 | > 0.05 |
| T(ng/dl) | 38.40 ± 16.22 | 46.36 ± 23.24 | > 0.05 |
| AMH (ng/ml) | 4.18 ± 1.54 | 10.51 ± 4.84 | < 0.05 |